 Introduction
Human
Veterinary
Environmental
 Industrial
Agricultural
Introduction
Medical
Veterinary
Environmental
Industrial
Agricultural
Introduction
Susceptibility
MIC Database
Procedures
Histopathology
Introduction
Abbreviations
Links
CME
Conference
Highlights
Bibliography
Glossary
Good Books
Events
Calendar
Introduction
Our Mission
Editorial Board
Editorial Staff
Supporters
Contributors
Legal Stuff
Privacy Policy
Kudos
This page updated:
1/7/2007 12:49:00 PM
DoctorFungus - All Rights Reserved
© 2007 Copyright
& Privacy Policy
Site built and designed for doctorfungus by Webillustrated
|
 |
 |
|
|
You are here:
The Fungi
> Descriptions >
|
|
Candida lipolytica
(Harrison) Diddens & Lodder (1942)
|
|
Yarrowia lipolytica (Wickerham, Kurtzman & Herman) van der Walt & von Arx (1980)
|
|
|
Colonies on Sabouraud dextrose agar at 25°C are off-white, dull and cerebriform. This isolate grows at 37°C and on media containing cycloheximide. The urease reaction is also positive.
On cornmeal following 72 hours incubation at 25°C, multi-branched true hyphae with rare blastoconidia may are seen. This species is likely to be indistinguishable from C. krusei on Chromager Candida [1069].
This species has been implicated as an emerging pathogen [1011], and has been reported in fungemia in both the adult [1774] and pediatric [2095] population. Candida lipolytica has also been reported as a cause in refractory oral candidiasis [2264].
| AMB |
CAS |
5FC |
FLU |
ITRA |
VORI |
| 0.125 µg/ml=1 |
0.125 µg/ml=2 |
<0.125 µg/ml=1 |
<0.125 µg/ml=1 |
0.03 µg/ml=1 |
<0.015 µg/ml=1 |
| 0.25 µg/ml=3 |
0.25 µg/ml=1 |
2.0 µg/ml=1 |
0.5 µg/ml=2 |
0.06 µg/ml=1 |
0.03 µg/ml=2 |
| 1.0 µg/ml=1 |
>16 µg/ml=1 |
16 µg/ml=1 |
1.0 µg/ml=1 |
0.125 µg/ml=2 |
0.5 µg/ml=1 |
| 2.0 µg/ml=3 |
|
|
2.0 µg/ml=2 |
0.25 µg/ml=1 |
|
| |
|
|
4.0 µg/ml=2 |
2.0 µg/ml=1 |
|
| |
|
|
32 µg/ml=2 |
4.0 µg/ml=1 |
|
| |
|
|
64 µg/ml=1 |
|
|
| Drug/N |
AMB/8 |
CAS/4 |
5FC/3 |
FLU/11 |
ITRA/7 |
VORI/4 |
| MIC Range |
0.125-2.0 |
0.125->16 |
<0.125-16 |
<0.125->64 |
0.03-4.0 |
<0.015-0.5 |
| MIC50 |
* |
* |
* |
2.0 |
* |
* |
| MIC90 |
* |
* |
* |
32 |
* |
* |
* Fungus Testing Laboratory unpublished data (NCCLS M27-A2)
PubMed
GenBank
|
|
|
References
1011. Hazen, K. C. 1995. New and emerging yeast pathogens. Clin Microbiol Rev. 8:462-78.
1069. Hospenthal, D. R., M. L. Beckius, K. L. Floyd, L. L. Horvath, and C. K. Murray. 2006. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida. Ann Clin Microbiol Antimicrob. 5:1.
1774. Pfaller, M. A., and D. J. Diekema. 2004. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect. 10:11-23.
2095. Shin, J. H., H. Kook, D. H. Shin, T. J. Hwang, M. Kim, S. P. Suh, and D. W. Ryang. 2000. Nosocomial cluster of Candida lipolytica fungemia in pediatric patients. Eur. J. Clin. Microbiol. Infect. Dis. 19:344-349.
2264. Tumbarello, M., G. Caldarola, E. Tacconelli, G. Morace, B. Posteraro, R. Cauda, and L. Ortona. 1996. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection. J. Antimicrob. Chemother. 38:691-699.
|